SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-15-008308
Filing Date
2015-01-12
Accepted
2015-01-12 17:25:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST- EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 d849826dposam.htm POS AM 680516
2 EX-23.1 d849826dex231.htm EX-23.1 1364
3 GRAPHIC g849826doc1.jpg GRAPHIC 9029
  Complete submission text file 0001193125-15-008308.txt   695628
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-192617 | Film No.: 15522724
SIC: 2834 Pharmaceutical Preparations